Peanut allergy immunotherapy startup gets $17M funding

Allergen Research Corp, a startup company based in California, has raised $17 million in Series A funding to get its immunotherapy kit put through mid-stage trials and ready for market.

The platform, which will initially target peanut allergies, is meant to be capable of being expanded to other allergens as well.

A unique treatment

The treatment uses a slow, steady up-dosing regimen of pharmaceutical-grade peanut proteins to reeducate the body's immune system to gradually diminish the body's negative responses to allergens like peanuts.

The trial will launch before the end of the year, the company says, targeting a 2015 release for its peanut allergy kit. They will be sold to allergists and qualified physicians and their offices for use in treating patients with peanut allergies.

Mid-stage trials for the kit are in the works for allergens like milk, soy, egg, wheat, shrimp, fish and other tree nuts over the next six years.

The unique aspect of the ARC kit is that it is an oral product requiring no injections or invasive procedures.

Peanut Free Store

More Articles

You already know that if you or your child has a peanut allergy you need to avoid peanut butter. Some...

There are many reasons why you may want to substitute almond flour for wheat flour in recipes. Of course, if you have a...

Are you looking for peanut-free candies as a special treat for a child with...

Do you have a child with peanut allergies and an upcoming birthday? Perhaps you'd like to bake a...

Most nut butters provide all the same benefits: an easy sandwich spread, a great dip for veggies, a fun addition to a smoothie. But not...

Top Forum Categories

Click on one of the categories below to see all topics and discussions.